ASTX-295 is under clinical development by Taiho Pharmaceutical and currently in Phase II for Solid Tumor. According to GlobalData, Phase II drugs for Solid Tumor have a 37% phase transition success ...

ASTX-295 is under clinical development by Taiho Pharmaceutical and currently in Phase II for Glioblastoma Multiforme (GBM).

Earlier partnerships have involved AstraZeneca and Revolution Medicines, Merck & Co and Taiho/Astex, Roche's Genentech unit and Relay Therapeutics and AbbVie and Jacobio. Meanwhile, Novartis seems ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Russia and other hostile states have become increasingly brazen in adopting “gray zone” attacks against Europe and the United States, leaving defense officials with a dilemma: How to respond ...

Dec. 30, 2024 — A new species of black, slender moray eel has chosen the road less traveled, thriving in dim and muddy river mouths, unlike most of its marine ... Six New Tree Species Named: 3 ...

New year, new food? Here’s what to know about the top diets of 2025 New year, new food? Here’s what to know about the top diets of 2025 As 2025 arrives, experts break down the trending diets ...

Christian converts in Kosovo, where the vast majority of people are Muslim, hope to revive a pre-Islamic past they see as a key to their European identity. By Andrew Higgins and Fatjona Mejdini ...

A Brazilian influencer whose staggering 32-stone weight loss made him the star of a reality TV show has died aged 37 after piling on the pounds again following the loss of his dad and brother ...

Jan. 2, 2025 — An enzyme called MICAL2 promotes tumor growth and metastasis in the most common form of pancreatic cancer, according to a new ... Advanced Imaging Uncovers Hidden Metastases in ...